Iogen Corporation to Review Strategic Alternatives

Ottawa (ots/PRNewswire) - Iogen Corporation today
announced that its Board of Directors has initiated a process to
explore strategic alternatives for enhancing shareholder value and
funding the deployment of its world leading renewable energy
technology. The company has retained Goldman, Sachs & Co. as its
exclusive financial advisor.

Iogen Corporation is a joint owner, with Royal Dutch Shell plc,
of Iogen Energy, the industry leader in developing commercial
technology for making cellulosic ethanol from agricultural residue.
Iogen Corporation also owns and operates, through its wholly-owned
Iogen Bio-Products subsidiary, a commercial enzyme business and
manufacturing facility serving customers globally.

"Iogen Corporation has developed advanced biofuel technology that
is ready to be deployed and enjoys a valuable set of commercial
development rights for that technology. Fully exploited, these rights
offer a tremendous business opportunity," said Clive Mather, Chairman
of Iogen Corporation. "At this time, the Board of Directors feels
that it is appropriate to examine all alternatives which will allow
the company to realize the potential of this technology and thereby
maximize shareholder value."

Iogen Corporation (http://www.iogen.ca) is a privately held
company located in Ottawa, Canada. In business since 1974, it
develops, manufactures and markets enzymes used to modify and
improve the processing of natural fibers within the textile, animal
feed, pulp and paper, grain processing and brewing industries. Iogen
Corporation also owns 50% of Iogen Energy and, like Shell, holds
significant independent rights to commercially exploit the Iogen
Energy cellulosic ethanol technology.

Iogen Energy, a 50-50 joint venture between Iogen Corporation and
Shell, is a leading biotechnology firm specializing in cellulosic
ethanol, which it has been producing from wheat straw at its Ottawa
demonstration plant since 2004. Development of the Iogen Energy
cellulosic demonstration plant as well as strategic research and
development in cellulosic ethanol technology was made possible in
part with the assistance of the Technology Partnerships Canada
Program (now administered by Industry Canada's Industrial
Technologies Office).

Iogen Bio-Products, a wholly-owned subsidiary of Iogen
Corporation, develops, manufactures and markets enzymes used to
modify and improve the processing of natural fibers within the
textile, animal feed, pulp and paper, grain processing and brewing
industries.

Royal Dutch Shell plc ("Shell") is incorporated in England and
Wales, has its headquarters in The Hague and is listed on the London,
Amsterdam and New York stock exchanges. Shell companies have
operations in more than 110 countries and territories, with
businesses including: bio-fuels; oil and gas exploration; production
and marketing of liquefied natural gas and gas to liquids; and the
marketing and shipping of oil products and chemicals.

For further information: For further information: Lisa Hanke,
Senior Associate, Public Affairs and Communications, Iogen
Corporation, +1-613-733-9830

ots Originaltext: Iogen Corporation
Im Internet recherchierbar: http://www.presseportal.de

Contact:
CONTACT: For further information: For further information: Lisa
Hanke,SeniorAssociate, Public Affairs and Communications, Iogen
Corporation,+1-613-733-9830